DIRECTOR OF BIOHIT'S DIAGNOSTICS BUSINESS RESIGNS
BIOHIT OYJ STOCK EXCHANGE RELEASE ON 24 SEPTEMBER 2009 AT 12:25
DIRECTOR OF BIOHIT'S DIAGNOSTICS BUSINESS RESIGNS
Peter Tchernych, Director of Biohit Oyj's diagnostics business, has today given
notice of his resignation from the company's employment due to personal reasons.
He will leave the company with immediate effect.
For the time being, President & CEO Osmo Suovaniemi will take care of the
international sales and management of the diagnostics business together with
Sales Director Päivi Lipponen (MSc) and R&D Director Lea Paloheimo (PhD). Päivi
Lipponen has been with Biohit since 2008 and Lea Paloheimo since 2001.
Biohit Oyj
Osmo Suovaniemi
President & CEO
Further information:
Osmo Suovaniemi, M.D., Ph.D., Professor
President & CEO
Tel: +358-9-773 861
GSM: +358-40-745 5605
Email: osmo.suovaniemi@biohit.com
Distribution:
NASDAQ OMX Helsinki Oy
Central storage facility (www.oam.fi)
Press
www.biohit.com
About Biohit Oyj
Biohit Oyj develops, manufactures and markets liquid handling products and
diagnostic test systems for use in research, health care and industrial
laboratories.
Liquid handling products include electronic and mechanical pipettes and
dispensers, and disposable tips, as well as pipette maintenance and calibration
services. Diagnostics business comprises products and analysis systems for
diagnosing, screening and prevention of gastrointestinal diseases, e.g. the
blood-sample based GastroPanel and GastroView, for diagnosing diseases of the
stomach and associated risks, as well as quick tests for the diagnosis of
lactose intolerance, H. pylori infection and fecal occult blood.
Biohit Oyj is headquartered in Finland. Biohit has subsidiaries in France,
Germany, the UK, Russia, China, Japan and the USA. Additionally, Biohit's
products are sold by approximately 450 distributors in 70 countries. Biohit's
share (BIOBV) is quoted on NASDAQ OMX Helsinki.
Read more at www.biohit.com